Control Bionics Limited (ASX: CBL) has announced a new agreement with Tobii Dynavox, a global leader in Augmentative and Alternative Communication (AAC), to evaluate a potential U.S. distribution partnership for its NeuroNode® technology. The agreement initiates a six-month pilot program across five north-western U.S. states, positioning NeuroNode alongside Tobii Dynavox’s established communication aids.

Actinogen Medical Limited (ASX: ACW) is progressing its lead drug candidate, Xanamem (emestedastat), through the XanaMIA Phase 2b/3 Alzheimer’s disease clinical trial being conducted across Australia and the United States. The Company is developing Xanamem as a once-daily oral therapy targeting cortisol regulation in the brain, to slow disease progression in patients with mild to moderate Alzheimer’s disease.

Adisyn Ltd (ASX: AI1) is advancing a graphene-based semiconductor technology platform through its wholly owned subsidiary, 2D Generation (2DG), supported by international research collaborations across Israel, Europe, and the United States. The Company’s core development work focuses on low-temperature graphene deposition processes designed for compatibility with existing semiconductor manufacturing environments.

Enova Mining Ltd has reported further results from its auger drilling program at the CODA East Project in Minas Gerais, Brazil. The program continues to define broad zones of near-surface titanium oxide, rare earth elements, and niobium mineralisation hosted within saprolitised kamafugite of the Patos Formation.

Samso continues to follow South Harz Potash (ASX: SHP) as it expands beyond its original potash focus into early-stage base and precious metals exploration. This update is relevant as it moves the Glava Project from historical context into modern field validation, with multiple datasets now pointing to scale, continuity, and follow-up drill potential.

OD6 Metals Limited (ASX: OD6) is advancing the Gulf Creek Copper Project in northern New South Wales, a historically mined, high-grade copper system. The Company has completed a Downhole Electromagnetic (DHEM) survey to support its recent diamond drilling program and improve targeting beneath historic workings.

Impact Minerals Limited (ASX: IPT) has released an update on its Lake Hope High Purity Alumina (HPA) Project in Western Australia (Figure 1), reporting strong technical progress achieved during the first 12 months of its A$2.87 million Cooperative Research Centres Projects (CRC-P) programme. The update highlights advances in membrane technologies applied to Impact’s patented three-stage HPA process.

The Salazar Critical Minerals Project is located approximately 120km north-east of Esperance, Western Australia, and comprises the Newmont and O’Connor deposits across a large saprolite-dominated clay system. Salazar is already recognised as one of Australia’s most advanced clay-hosted critical minerals projects, hosting significant rare earth, scandium, titanium dioxide, alumina, and now gallium Mineral Resources.

Cazaly Resources Limited (ASX: CAZ) has achieved its first earn-in milestone at the Goongarrie Gold Project, located approximately 90 kilometres north of Kalgoorlie in Western Australia’s northeastern goldfields (Figure 1). The update confirms completion of the Phase 1 farm-in expenditure, securing an initial 25% interest in the project and advancing exploration along a gold-mineralised structural corridor.

Cyprium Metals Limited (ASX: CYM) has provided an update on its Paterson Exploration Project in Western Australia, following the completion of a first-pass review of exploration data returned after regaining full control of the tenement package. The review focuses on the Rainbow and Rainbow South areas, located north of the Nifty Copper Complex, where historic drilling, geophysics, and surface data are being used to refine copper targets and guide upcoming exploration program

Samso continues to follow OD6 Metals Ltd (ASX: OD6) as it advances Splinter Rock from resource definition into processing optimisation and commercial readiness. This update is relevant as it focuses on metallurgical de-risking, product qualification, and offtake preparation rather than exploration upside alone, which is a key transition phase for clay-hosted rare earth projects.

Echo IQ Limited (ASX: EIQ) is an Australian AI and medical technology company focused on improving decision-making in cardiology. Its lead product, EchoSolv HF, is a heart failure clinical decision support software designed to assist clinicians in detecting heart failure using echocardiogram data. The Company’s recent announcements outline the completion of clinical validation with the Mayo Clinic Platform and the subsequent formal lodgement of an FDA 510(k) submission in the